查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1732945

人造血管市场－全球产业规模、份额、趋势、机会及预测（按应用、按聚合物、按地区及竞争细分，2020-2030 年）

Artificial Blood Vessels Market - Global Industry Size, Share, Trends, Opportunity, & Forecast Segmented By Application, By Polymer, By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 183 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球人工血管市场价值为 3.0158 亿美元，预计到 2030 年将达到 4.2151 亿美元，预测期内复合年增长率为 5.74%。该市场是医疗器材产业的一个重要领域，专注于治疗心血管和血管疾病的血管移植的开发和应用。人工血管，包括合成的和组织工程的，对于搭桥手术、血液透析通路和主动脉修復等救生手术来说都是不可或缺的，尤其是在天然血管不适合或无法使用的情况下。该领域在材料科学和移植物设计方面取得了显着进步，提高了安全性、耐用性和手术效果。此外，微创手术的转变加速了对先进血管移植的需求，从而减少了恢復时间和手术风险，为市场持续成长奠定了基础。

市场概览
预测期 2026-2030
2024年市场规模 3.0158亿美元
2030年市场规模 4.2151亿美元
2025-2030 年复合年增长率 5.74%
成长最快的领域 主动脉疾病
最大的市场 北美洲

关键市场驱动因素

心血管疾病盛行率上升

主要市场挑战

监管障碍和审批流程

主要市场趋势

可生物降解和生物工程材料

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球人造血管市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 依应用（主动脉疾病、週边动脉疾病、血液透析）
    • 依聚合物（聚二噁烷酮、弹性体、聚对苯二甲酸乙二酯、其他）
    • 按地区
    • 按公司分类（2024）
  • 市场地图

第六章：北美人造血管市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第七章：欧洲人造血管市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲：国家分析
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙

第八章：亚太人造血管市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：南美洲人造血管市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第十章：中东和非洲人造血管市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA：国家分析
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章：市场动态

  • 驱动程式
  • 挑战

第 12 章：市场趋势与发展

  • 最新动态
  • 产品发布
  • 併购

第 13 章：全球人造血管市场：SWOT 分析

第 14 章：竞争格局

  • B. Braun Melsungen
  • Becton, Dickinson and Company
  • Cook Medical Incorporated
  • Humacyte Inc.
  • Jotec GmbH
  • LeMaitre Vascular Inc
  • Medtronic Inc
  • Techshot Inc
  • Terumo Medical Corporation
  • WL Gore & Associates, Inc.

第 15 章：策略建议

第16章调查会社について・免责事项

简介目录
Product Code: 16268

The Global Artificial Blood Vessels Market was valued at USD 301.58 million in 2024 and is projected to reach USD 421.51 million by 2030, expanding at a CAGR of 5.74% during the forecast period. This market represents a vital segment of the medical device industry, focusing on the development and application of vascular grafts for treating cardiovascular and vascular conditions. Artificial blood vessels, both synthetic and tissue-engineered, are integral to life-saving procedures such as bypass surgeries, hemodialysis access, and aortic repair, especially when natural vessels are unsuitable or unavailable. The sector has seen notable advancements in material science and graft design, enhancing safety, durability, and surgical outcomes. Additionally, the shift towards minimally invasive procedures has accelerated demand for advanced vascular grafts that reduce recovery times and procedural risks, positioning the market for sustained growth.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 301.58 Million
Market Size 2030USD 421.51 Million
CAGR 2025-20305.74%
Fastest Growing SegmentAortic Disease
Largest MarketNorth America

Key Market Drivers

Rising Prevalence of Cardiovascular Diseases

The escalating incidence of cardiovascular diseases-such as coronary artery and peripheral arterial diseases-serves as a major catalyst for the artificial blood vessels market. This rise is driven by sedentary lifestyles, increased consumption of processed foods, and a surge in obesity and diabetes, all contributing to vascular complications. The global trend of aging populations further exacerbates vulnerability to arterial disorders due to natural physiological changes. According to the World Health Organization, cardiovascular diseases account for approximately 17.9 million deaths annually, highlighting the urgent need for advanced vascular solutions. A hereditary predisposition to heart disease and the health impacts of urbanization, including pollution and stress, also heighten the need for effective interventions like artificial grafts, thereby stimulating market growth.

Key Market Challenges

Regulatory Hurdles and Approval Processes

One of the major challenges facing the artificial blood vessels market is navigating the stringent regulatory frameworks required for medical device approval. Compliance with rigorous standards from authorities such as the FDA and EMA involves lengthy and costly clinical evaluations, often delaying product launches. These regulatory procedures can vary significantly across regions, complicating global distribution strategies. Additionally, the focus on patient safety means that any adverse events or safety concerns can trigger intensified scrutiny, potential recalls, and prolonged approval timelines, thereby impeding market entry and expansion.

Key Market Trends

Biodegradable and Bioengineered Materials

A significant trend in the artificial blood vessels market is the adoption of biodegradable and bioengineered materials that emulate the characteristics of natural vessels. These innovations enhance biocompatibility and minimize risks of clotting or immune reactions. Designed to gradually dissolve and integrate with patient tissue, these materials can help reduce long-term complications such as graft failure or calcification. Moreover, their customizable nature allows for tailored solutions that align with individual patient anatomies, improving fit and performance while reducing the risk of rejection, thus paving the way for personalized vascular care.

Key Market Players

  • B. Braun Melsungen
  • Becton, Dickinson and Company
  • Cook Medical Incorporated
  • Humacyte Inc.
  • Jotec GmbH
  • LeMaitre Vascular Inc
  • Medtronic Inc
  • Techshot Inc
  • Terumo Medical Corporation
  • W. L. Gore & Associates, Inc.

Report Scope:

In this report, the Global Artificial Blood Vessels Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Artificial Blood Vessels Market, By Application:

  • Aortic Disease
  • Peripheral Artery Disease
  • Haemodialysis

Artificial Blood Vessels Market, By Polymer:

  • Polydioxanone
  • Elastomer
  • Polyethylene Terephthalate
  • Others

Artificial Blood Vessels Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Artificial Blood Vessels Market.

Available Customizations:

Global Artificial Blood Vessels market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Artificial Blood Vessels Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application (Aortic Disease, Peripheral Artery Disease, Haemodialysis)
    • 5.2.2. By Polymer (Polydioxanone, Elastomer, Polyethylene Terephthalate, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Artificial Blood Vessels Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application
    • 6.2.2. By Polymer
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Artificial Blood Vessels Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Application
        • 6.3.1.2.2. By Polymer
    • 6.3.2. Canada Artificial Blood Vessels Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Application
        • 6.3.2.2.2. By Polymer
    • 6.3.3. Mexico Artificial Blood Vessels Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Application
        • 6.3.3.2.2. By Polymer

7. Europe Artificial Blood Vessels Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By Polymer
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Artificial Blood Vessels Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Application
        • 7.3.1.2.2. By Polymer
    • 7.3.2. United Kingdom Artificial Blood Vessels Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Application
        • 7.3.2.2.2. By Polymer
    • 7.3.3. Italy Artificial Blood Vessels Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Application
        • 7.3.3.2.2. By Polymer
    • 7.3.4. France Artificial Blood Vessels Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Application
        • 7.3.4.2.2. By Polymer
    • 7.3.5. Spain Artificial Blood Vessels Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Application
        • 7.3.5.2.2. By Polymer

8. Asia-Pacific Artificial Blood Vessels Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By Polymer
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Artificial Blood Vessels Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Application
        • 8.3.1.2.2. By Polymer
    • 8.3.2. India Artificial Blood Vessels Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Application
        • 8.3.2.2.2. By Polymer
    • 8.3.3. Japan Artificial Blood Vessels Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Application
        • 8.3.3.2.2. By Polymer
    • 8.3.4. South Korea Artificial Blood Vessels Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Application
        • 8.3.4.2.2. By Polymer
    • 8.3.5. Australia Artificial Blood Vessels Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Application
        • 8.3.5.2.2. By Polymer

9. South America Artificial Blood Vessels Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By Polymer
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Artificial Blood Vessels Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Application
        • 9.3.1.2.2. By Polymer
    • 9.3.2. Argentina Artificial Blood Vessels Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Application
        • 9.3.2.2.2. By Polymer
    • 9.3.3. Colombia Artificial Blood Vessels Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Application
        • 9.3.3.2.2. By Polymer

10. Middle East and Africa Artificial Blood Vessels Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application
    • 10.2.2. By Polymer
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Artificial Blood Vessels Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Application
        • 10.3.1.2.2. By Polymer
    • 10.3.2. Saudi Arabia Artificial Blood Vessels Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Application
        • 10.3.2.2.2. By Polymer
    • 10.3.3. UAE Artificial Blood Vessels Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Application
        • 10.3.3.2.2. By Polymer

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Artificial Blood Vessels Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. B. Braun Melsungen
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. Becton, Dickinson and Company
  • 14.3. Cook Medical Incorporated
  • 14.4. Humacyte Inc.
  • 14.5. Jotec GmbH
  • 14.6. LeMaitre Vascular Inc
  • 14.7. Medtronic Inc
  • 14.8. Techshot Inc
  • 14.9. Terumo Medical Corporation
  • 14.10. W. L. Gore & Associates, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer